IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
16 hedge funds and large institutions have $684K invested in ImmunoCellular Therapeutics, Ltd. in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
-15
Holders Change %
-48.39%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
4
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Renaissance Technologies
New York
|
$200K |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
$125K |
3 |
UBS Group
Zurich,
Switzerland
|
$2K |
4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
$1K |